SLC5A2 and hydrops fetalis: Interestingly, a recent mediation analysis in the Canagliflozin Cardiovascular Assessment Study (CANVAS) program reported that the decrease in NT-proBNP concentration caused by treatment with a SGLT2 inhibitor was associated with a relatively small reduction in the risk of HF-related events [34].